Interleukin-6 is a growth factor for nonmalignant human plasmablasts.

Area of Science:

• Immunology
• Cell Biology
• Hematology

Background:

• Interleukin-6 (IL-6) is recognized for its role in B-cell differentiation.
• Recent findings suggest IL-6 is crucial for human plasmablast survival in vivo.
• The precise roles of IL-6 and IL-2 in plasma cell generation from memory B cells require further investigation.

Purpose of the Study:

• To re-evaluate the functions of IL-6 and IL-2 in the in vitro generation of plasma cells from human memory B cells.
• To identify the specific B-cell subsets involved in this differentiation process.
• To elucidate the synergistic or independent roles of IL-2 and IL-6 in plasma cell development.

Main Methods:

• Human memory B cells were cultured in vitro with various cytokines, including IL-2, IL-10, and IL-6.
• Cell populations were identified using flow cytometry based on CD20, CD38, and CD138 expression.
• The expression levels of IL-2 receptor alpha (CD25) and IL-6 receptor alpha (CD126) were analyzed.
• Monoclonal antibodies against IL-6 were used to assess the impact of IL-6 blockade.

Main Results:

• IL-2 or IL-10 strongly induced plasmablast and early plasma cell (PC) generation.
• IL-6 alone showed limited efficacy in PC generation but enhanced early PC generation when combined with IL-2 or IL-10.
• Anti-IL-6 antibodies significantly reduced IL-2-induced early PC generation, but not plasmablast generation.
• IL-6 was found to enhance the proliferation of IL-2-generated plasmablasts.

Conclusions:

• IL-6 functions as a growth factor for nonmalignant human plasmablasts.
• The study highlights a differential role for IL-6 and IL-2 in plasma cell differentiation and proliferation.
• Findings provide insights into the complex cytokine networks regulating B-cell terminal differentiation.